FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
PD Dr. Fabian Müller
Orcid ID:
0000-0001-5487-5839
List of publications:
BibTeX-Download
Medizinische Fakultät
Department of Medicine 5 – Haematology and Oncology
Professur für CAR-T-Zell-Therapie
Project Leads
(2)
Publications
(56)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025)
Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al.
Journal article
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024)
Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al.
Journal article
Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells (2024)
Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, et al.
Journal article
CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024)
Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al.
Journal article
Selective CAR T cell–mediated B cell depletion suppresses IFN signature in SLE (2024)
Wilhelm A, Chambers D, Müller F, Bozec A, Grieshaber Bouyer R, Winkler T, Mougiakakos D, et al.
Journal article
CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis (2024)
Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spörl S, Vasova I, et al.
Journal article
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. (2024)
Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldés A, et al.
Journal article
Advancements and challenges in CAR T cell therapy in autoimmune diseases (2024)
Schett G, Müller F, Taubmann J, Mackensen A, Wang W, Furie RA, Gold R, et al.
Journal article, Review article
CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher? (2024)
Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber Bouyer R, Schett G
Journal article
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. (2024)
Rejeski K, Wang Y, Hansen DK, Iacoboni G, Bachy E, Bansal R, Penack O, et al.
Journal article
‹
1
2
3
...
6
›